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Introduction
An increase in serum levels of the parathyroid hor-
mone (PTH) and hyperplasia of the parathyroid glands
have been observed to occur in the early stages of
chronic kidney disease with decreased renal function,
in an attempt to maintain serum calcium within the
normal range [1]. However, this secondary hyperpara-
thyroidism becomes maladaptive when chronic renal
failure progresses to end-stage renal failure, leading
to severe hyperparathyroidism, which is refractory to
medical therapy. When severe hyperparathyroidism
is associated with hypercalcaemia and/or hyperphos-
phataemia, parathyroidectomy (PTX) should be con-
sidered. However, PTX in such cases can often result
in an acute decrease of serum calcium and is one of
the leading causes of acute hypocalcaemia. Hypocal-
caemia is associated with a wide spectrum of symp-
toms and signs, mostly related to acute changes in
serum calcium, rather than constantly low levels [2].
Among them, neuromuscular dysfunction, including
tetany and seizure, is the hallmark of the clinical
manifestations of acute hypocalcaemia. On the other
hand, transient diplopia has been reported only rarely.
To illustrate this association, we report on three
patients who, following PTX for severe hyperparathy-
roidism, experienced acute hypocalcaemia and there-




The ﬁrst patient was a 39-year-old man on maintenance
haemodialysis (HD) since November 1990, with end-
stage renal failure secondary to chronic glomerulone-
phritis. In 1992 and 1996, he underwent cadaveric
kidney transplantation with an unsuccessful outcome.
Due to severe hyperparathyroidism, a total PTX with
autotransplant of parathyroid tissue in the right arm
was performed in August 1993. From 1999 onwards,
secondary hyperparathyroidism progressively recurred,
with a serum PTH level of 173 pmol/l (normal range:
1.1–6.9 pmol/l). Serum calcium was normal at
2.39mmol/l (normal range: 2.2–2.6mmol/l). The
pre-operative serum alkaline phosphatase level was
also normal at 82U/l (normal range: 30–125U/l).
Recurrence was attributed to hyperplasia of the right
arm’s parathyroid tissue. The patient was receiving
1600mg elemental calcium a day, but no vitamin D
derivatives. Excision of the remaining parathyroid
tissue of the patient’s right arm was carried out in
February 2003. Three days after surgery, he experi-
enced general numbness due to severe hypocal-
caemia. Since his albumin-adjusted calcium was only
1.5mmol/l, he was prescribed a calcium supplement
(1000mg daily), calcitriol and the dose of active vitamin
D was progressively increased. The dialysate calcium
level was also increased from 1.5 to 1.75mmol/l. The
serum calcium level (and associated symptoms) then
began to ﬂuctuate, being normal immediately after his
dialysis session and low in-between. One week later, he
complained of transient diplopia along with generalized
dysesthesia (pins and needles) associated with muscle
cramps. Horizontal binocular diplopia was noticed
while looking on the right side, with weakness of the left
medial rectus. No other speciﬁc neurological abnorm-
alities were detected. Chvostek’s and Trousseau’s
signs were absent. Laboratory investigations revealed
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hypocalcaemia (1.79mmol/l) and hyperphosphataemia
(1.92mmol/l; normal range: 0.80–1.40mmol/l). Serum
potassium and magnesium were within the normal
range. The intact PTH level (12.4 pmol/l) had decreased
markedly as compared with its pre-operative level
and the acid–base balance was unremarkable. Within
24 h of transient normalization of the serum calcium
with a dialysis session, diplopia did not recur.
Case 2
This patient was a 26-year-old woman with end-stage
renal failure secondary to reﬂux nephropathy, on main-
tenance HD since 1995. A subtotal PTX was performed
in June 2003 for secondary hyperparathyroidism with
a very high serum PTH (453 pmol/l) and serum alkaline
phosphatase levels (632U/l; normal range: 32–104U/l),
although the protein-corrected serum calcium level
was normal (2.28mmol/l). At the time of surgery, she
was receiving 1200mg elemental calcium and 0.25 mg
calcitriol a day. The day after surgery, she experienced
very transient diplopia with dysesthesia and muscle
cramps. At that time, ophthalmological and neuro-
logical evaluations were normal, but Chvostek’s and
Trousseau’s signs were present. A marked decrease in
serum calcium to 1.74mmol/l, with a possible hungry
bone syndrome (the intact PTH level was 32 pmol/l),
developed the day after surgery. Laboratory investiga-
tion also revealed hyperphosphataemia (2.02mmol/l)
and hyperkalaemia (7.2mmol/l; normal range: 3.6–
4.6mmol/l), although magnesium concentration was
normal (0.79mmol/l; normal range: 0.65–1.05mmol/l),
as was the bicarbonate level. After intravenous
administration of large amounts of calcium gluconate
(10%) and oral calcium over the next 24 h, the level
of serum calcium became normal and the symptoms
disappeared.
Case 3
The third patient was a 42-year-old man with pre-
dialysis renal failure secondary to obstructive nephro-
pathy. In January 2000, he underwent a total PTX
with autotransplantation for severe hyperparathyroid-
ism [intact PTH: 132 pmol/l; protein-corrected serum
calcium: 2.20mmol/l; high levels of alkaline phos-
phatase: 403U/l (normal range: 98–279U/l)]. At that
time, he was receiving 1.5 mg calcitriol once a day.
Hypocalcaemia developed 24 h after surgery. Despite
the introduction of a large dose of calcium (12 g per
day) and increasing the dose of calcitriol to 2 mg per
day, 10 days after surgery he complained of paresthe-
siae of the distal extremities and circum-oral area,
Chvostek’s and Trousseau’s signs and muscle cramps.
He also complained of transient diplopia, but clinical
examination revealed no abnormalities. Laboratory
investigations on readmission after surgery showed
marked hypocalcaemia (1.32mmol/l), hyperphos-
phataemia (2.17mmol/l) and hypomagnesaemia
(0.57mmol/l). Hypoparathyroidism was diagnosed on
the basis of low levels of PTH in the serum (1.1 pmol/l).
With calcium supplements and active vitamin D deriva-
tives, the serum calcium increased slowly and became
normal within 1 week.
Discussion
We have described three patients with ESRD who
presented with transient diplopia, in the absence of
other causes of neurological disorder, and acute hypo-
calcaemia following a PTX for renal hyperparathy-
roidism. The common characteristic of these patients
was rapidly developing hypocalcaemia as well as
manifestations of neuromuscular irritability. In all
three cases, the duration of double vision was brief
and binocular and on clinical examination no speciﬁc
ophthalmological or neurological abnormalities were
detected.
Diplopia in these cases was most probably a mani-
festation of tetany of the extraocular muscles induced
by hypocalcaemia. Acute hypocalcaemia directly
increases peripheral neuromuscular irritability [3]. The
primary determinants of symptoms and signs in
patients with hypocalcaemia are related to the kinetics
and relative change of serum calcium. PTX performed
on these patients led to a marked decrease in serum
calcium within a few days of the operation.
Other factors could contribute to this clinical
presentation, including the acid–base status (although
no such modiﬁcations were observed), magnesium
depletion, a potassium imbalance and emotional
stress after surgery, all of which could affect epinephr-
ine concentrations and elicit tetany in patients with
hypocalcaemia [4].
Classically, tetany can affect all muscles except
the extraocular ones [5]. Nevertheless, diplopia has
been observed in patients with hypocalcaemia. For
example, a report described a 15-year-old boy com-
plaining of attacks of a thick tongue, double vision
and heart failure. He was diagnosed as having
idiopathic hypoparathyroidism with marked hypo-
calcaemia (1.09mmol/l) [6]. Another report described
a 74-year-old male with idiopathic hypoparathy-
roidism revealed by a non-insulin-dependent dia-
betes mellitus and severe hypocalcaemia (1.6mmol/l)
[7]. However, to our knowledge, diplopia was not
observed after PTX. An article published in 1960
stated that patients with severe hypocalcaemia after
a subtotal PTX for renal hyperparathyroidism could
experience blurring of vision and difﬁculty in accom-
modation [8].
These case reports raise the question of prevention
of post-PTX hypocalcaemia. Given the frequency of
this complication, a daily follow-up of serum calcium
is mandatory. Pre-operative administration of calcitriol
to all such patients if they are not already being treated
with a vitamin D metabolite should be recommended
as well as early administration of high doses of oral
calcium. Accordingly, a clinical algorithm has been
proposed recently [9].
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In conclusion, diplopia is a rare manifestation of
acute hypocalcaemia and should be noted as a potential
complication of PTX in dialysis patients. Although
rare, if this complication were made known to
nephrologists it could avoid unnecessary neurological
investigations.
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